Daniel S Metzinger Selected Research

Daniel S Metzinger Research Topics

5	Neoplasms (Cancer) 01/2021 - 07/2003
5	Ovarian Neoplasms (Ovarian Cancer) 02/2010 - 02/2005
2	Endometrial Neoplasms (Endometrial Cancer) 06/2021 - 09/2011
1	Vaginal Neoplasms (Cancer, Vaginal) 01/2021
1	Endometrioid Carcinoma 01/2021
1	Fistula 07/2017
1	Vesicovaginal Fistula 07/2017
1	Adenomyoma 01/2012
1	Wounds and Injuries (Trauma) 09/2011
1	Wound Infection (Wound Infections) 09/2011
1	Ovarian Diseases (Ovarian Disease) 02/2010
1	Ovarian Epithelial Carcinoma 01/2010
1	Adenocarcinoma 04/2007
1	Carcinoma (Carcinomatosis) 04/2007
1	Warts (Wart) 02/2005
1	Leiomyosarcoma 06/2003

2	Cisplatin (Platino)FDA LinkGeneric 04/2007 - 05/2006
1	Polyglactin 910IBA 07/2017
1	Immunoglobulin G (IgG)IBA 02/2010
1	Neoplasm Antigens (Tumor Antigens)IBA 02/2010
1	Proteins (Proteins, Gene)FDA Link 02/2010
1	Biomarkers (Surrogate Marker)IBA 02/2010
1	AntigensIBA 02/2010
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 04/2007
1	Paclitaxel (Taxol)FDA LinkGeneric 05/2006

4	Drug Therapy (Chemotherapy) 01/2021 - 05/2006
3	Radiotherapy 01/2021 - 02/2005
2	Brachytherapy 06/2021 - 01/2021
2	Hysterectomy 01/2021 - 01/2012
2	Lymph Node Excision (Lymph Node Dissection) 01/2021 - 09/2011
2	Laparotomy 09/2011 - 02/2005
2	Hyperthermic Intraperitoneal Chemotherapy 01/2010 - 04/2007
2	Therapeutics 04/2007 - 06/2003
1	Time-to-Treatment 01/2021
1	Duration of Therapy 01/2021
1	Adjuvant Chemotherapy 01/2021
1	Adjuvant Radiotherapy 01/2021
1	Chemoradiotherapy 01/2021
1	Pessaries 07/2017
1	Cystotomy 07/2017
1	Sutures (Suture) 07/2017
1	Length of Stay 04/2011
1	Neoadjuvant Therapy 04/2011
1	Immunotherapy 07/2003